Momenta Pharmaceuticals, Inc. (MNTA)

[RockRat]

"So not sure what you are implying here that Baxter did not like mnta ivig program" Exactly, with emphasis on "did." Baxter is a big player in IVig, and has presumably seen both programs. OTOH, perhaps MNTA's more recent improvements make it more attractive now relative to Gliknik. I can't get a handle on how well the two companies' programs compare, as Gliknik hasn't put a number on the potency of their candidates that I have found.

If sialylation is to be a saving grace for MNTA, it would behoove us to check out the competing efforts. There may be others. For example, one of the patents Floblu just posted relates to Alzheimer's. Sanofi is also playing in that area with similar tech. Gliknik's only disclosed indication so far is myasthenia gravis.

Regards, RockRat